This protocol is judged by an institutional review board, an independent team that evaluations any medical trials involving human beings. If a research will involve a Schedule I drug, when the board approves the protocol as moral, the scientists must apply for an investigational new drug (IND) variety in the FDA.“It’s vital that you keep in min